| Tumor targeting via EPR: Strategies to enhance patient responses SK Golombek, JN May, B Theek, L Appold, N Drude, F Kiessling, ... Advanced drug delivery reviews 130, 17-38, 2018 | 1119 | 2018 |
| Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications LY Rizzo, B Theek, G Storm, F Kiessling, T Lammers Current opinion in biotechnology 24 (6), 1159-1166, 2013 | 385 | 2013 |
| Passive versus active tumor targeting using RGD-and NGR-modified polymeric nanomedicines S Kunjachan, R Pola, F Gremse, B Theek, J Ehling, D Moeckel, ... Nano letters 14 (2), 972-981, 2014 | 353 | 2014 |
| Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π–Π Stacking Stabilized Polymeric Micelles Y Shi, R Van Der Meel, B Theek, E Oude Blenke, EHE Pieters, ... ACS nano 9 (4), 3740-3752, 2015 | 205 | 2015 |
| Motion model ultrasound localization microscopy for preclinical and clinical multiparametric tumor characterization T Opacic, S Dencks, B Theek, M Piepenbrock, D Ackermann, A Rix, ... Nature communications 9 (1), 1-13, 2018 | 198 | 2018 |
| Engineering biofunctional in vitro vessel models using a multilayer bioprinting technique J Schöneberg, F De Lorenzi, B Theek, A Blaeser, D Rommel, ... Scientific reports 8 (1), 10430, 2018 | 191 | 2018 |
| Image-guided, targeted and triggered drug delivery to tumors using polymer-based microbubbles S Fokong, B Theek, Z Wu, P Koczera, L Appold, S Jorge, U Resch-Genger, ... Journal of controlled release 163 (1), 75-81, 2012 | 175 | 2012 |
| Micro-CT imaging of tumor angiogenesis: quantitative measures describing micromorphology and vascularization J Ehling, B Theek, F Gremse, S Baetke, D Möckel, J Maynard, SA Ricketts, ... The American journal of pathology 184 (2), 431-441, 2014 | 167 | 2014 |
| Sonoporation enhances liposome accumulation and penetration in tumors with low EPR B Theek, M Baues, T Ojha, D Möckel, SK Veettil, J Steitz, L van Bloois, ... Journal of controlled release 231, 77-85, 2016 | 158 | 2016 |
| Noninvasive optical imaging of nanomedicine biodistribution S Kunjachan, F Gremse, B Theek, P Koczera, R Pola, M Pechar, T Etrych, ... ACS nano 7 (1), 252-262, 2013 | 134 | 2013 |
| Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imaging B Theek, F Gremse, S Kunjachan, S Fokong, R Pola, M Pechar, ... Journal of controlled release 182, 83-89, 2014 | 124 | 2014 |
| Biofabrication under fluorocarbon: a novel freeform fabrication technique to generate high aspect ratio tissue-engineered constructs A Blaeser, DF Duarte Campos, M Weber, S Neuss, B Theek, H Fischer, ... BioResearch open access 2 (5), 374-384, 2013 | 106 | 2013 |
| The theranostic path to personalized nanomedicine B Theek, LY Rizzo, J Ehling, F Kiessling, T Lammers Clinical and translational imaging 2, 67-76, 2014 | 87 | 2014 |
| Overcoming cellular multidrug resistance using classical nanomedicine formulations S Kunjachan, A Błauż, D Möckel, B Theek, F Kiessling, T Etrych, K Ulbrich, ... European journal of pharmaceutical sciences 45 (4), 421-428, 2012 | 74 | 2012 |
| Advanced ultrasound technologies for diagnosis and therapy A Rix, W Lederle, B Theek, T Lammers, C Moonen, G Schmitz, F Kiessling Journal of Nuclear Medicine 59 (5), 740-746, 2018 | 64 | 2018 |
| Absorption reconstruction improves biodistribution assessment of fluorescent nanoprobes using hybrid fluorescence-mediated tomography F Gremse, B Theek, S Kunjachan, W Lederle, A Pardo, S Barth, ... Theranostics 4 (10), 960, 2014 | 58 | 2014 |
| What scans we will read: imaging instrumentation trends in clinical oncology T Beyer, L Bidaut, J Dickson, M Kachelriess, F Kiessling, R Leitgeb, J Ma, ... Cancer Imaging 20, 1-38, 2020 | 57 | 2020 |
| Radiomic analysis of contrast-enhanced ultrasound data B Theek, T Opacic, Z Magnuska, T Lammers, F Kiessling Scientific reports 8 (1), 11359, 2018 | 40 | 2018 |
| Multimodal and multiscale optical imaging of nanomedicine delivery across the blood-brain barrier upon sonopermeation JN May, SK Golombek, M Baues, A Dasgupta, N Drude, A Rix, D Rommel, ... Theranostics 10 (4), 1948, 2020 | 38 | 2020 |
| Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors B Theek, M Baues, F Gremse, R Pola, M Pechar, I Negwer, K Koynov, ... Journal of controlled release 282, 25-34, 2018 | 38 | 2018 |
